Cisplatin
- Generic Name
- Cisplatin
- Brand Names
- Platinol
- Drug Type
- Small Molecule
- Chemical Formula
- Cl2H6N2Pt
- CAS Number
- 15663-27-1
- Unique Ingredient Identifier
- Q20Q21Q62J
- Background
Cisplatin, cisplatinum or cis-diamminedichloroplatinum(II) (CDDP) is a platinum-based chemotherapy drug used to treat various types of cancers, including sarcomas, some carcinomas (e.g. small cell lung cancer, and ovarian cancer), lymphomas and germ cell tumors. It was the first member of its class, which now also includes carboplatin and oxaliplatin.
- Indication
For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer.
- Associated Conditions
- Advanced Ovarian Cancer, Ovarian Cancer Metastatic, Advanced Bladder cancer, Advanced Testicular cancer, Metastatic Testicular cancer
Bristol-Myers Squibb: 150 Years of Pharmaceutical Innovation and Global Healthcare Leadership
• Bristol-Myers Squibb, founded in 1858, has evolved from a small Brooklyn pharmaceutical company to a global healthcare leader with approximately 28,000 employees and focus on six core therapeutic areas.
• The company's landmark merger in 1989 created a pharmaceutical powerhouse with combined profits of $1.3 billion, leading to over 60 product lines generating $50+ million in annual sales by 1995.
• BMS maintains a robust pipeline with 40 compounds in exploratory development and 6 in late-stage development, despite facing patent expiration challenges for key drugs like Plavix and Avapro.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath